RxNorm 1368403 NDC Crossover
alogliptin 12.5 MG / pioglitazone 15 MG Oral Tablet
Related NDC Codes to RxNorm Concept 1368403
The following NDC codes crossover to the RxNorm Concept 1368403. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
45802-238 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
45802-260 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
45802-304 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
45802-351 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
45802-402 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
45802-499 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE |